- United Kingdom
- /
- Software
- /
- AIM:BGO
Further weakness as Bango (LON:BGO) drops 11% this week, taking three-year losses to 65%
Investing in stocks inevitably means buying into some companies that perform poorly. But the last three years have been particularly tough on longer term Bango PLC (LON:BGO) shareholders. So they might be feeling emotional about the 65% share price collapse, in that time. And over the last year the share price fell 21%, so we doubt many shareholders are delighted. The falls have accelerated recently, with the share price down 19% in the last three months.
Since Bango has shed UK£7.3m from its value in the past 7 days, let's see if the longer term decline has been driven by the business' economics.
Given that Bango didn't make a profit in the last twelve months, we'll focus on revenue growth to form a quick view of its business development. When a company doesn't make profits, we'd generally hope to see good revenue growth. As you can imagine, fast revenue growth, when maintained, often leads to fast profit growth.
In the last three years, Bango saw its revenue grow by 28% per year, compound. That is faster than most pre-profit companies. The share price has moved in quite the opposite direction, down 18% over that time, a bad result. This could mean hype has come out of the stock because the losses are concerning investors. When we see revenue growth, paired with a falling share price, we can't help wonder if there is an opportunity for those who are willing to dig deeper.
You can see how earnings and revenue have changed over time in the image below (click on the chart to see the exact values).
If you are thinking of buying or selling Bango stock, you should check out this FREE detailed report on its balance sheet.
A Different Perspective
Investors in Bango had a tough year, with a total loss of 21%, against a market gain of about 23%. However, keep in mind that even the best stocks will sometimes underperform the market over a twelve month period. Regrettably, last year's performance caps off a bad run, with the shareholders facing a total loss of 10% per year over five years. We realise that Baron Rothschild has said investors should "buy when there is blood on the streets", but we caution that investors should first be sure they are buying a high quality business. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. Like risks, for instance. Every company has them, and we've spotted 2 warning signs for Bango (of which 1 is a bit unpleasant!) you should know about.
If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of companies that have proven they can grow earnings.
Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on British exchanges.
Valuation is complex, but we're here to simplify it.
Discover if Bango might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About AIM:BGO
Bango
Develops, markets, and sells technology that enables the marketing and sale of products and services to mobile phone users.
Undervalued with slight risk.
Similar Companies
Market Insights
Weekly Picks

This small biotech is developing technology that could potentially change how tissue is rebuilt

The Picks-and-Shovels Leader of the Grid Supercycle
KRMN — Karman Space & Defense: Down 58% from Peak, Is the Market Mispricing a Hypergrowth Defense Compounder?

Invinity Energy Systems: All About That BESS
Recently Updated Narratives

Luca Mining, $176M Revenue, Strong FCF, 200K Oz AuEq Vision & Debt-Free by Mid-2026

The Asymmetric TechBio Play: MindWalk Holdings and the Valuation Disconnect
PROCEPT BioRobotics sees 17.69% revenue growth and aims for 12.94% profit margin
Popular Narratives

Investment Analysis (May 2026)

Adobe: A Probabilistic Case for Undervaluation
